Boston Scientific BSX has delivered an impressive return over the past year, with shares rallying 40.5%. The performance outpaced the industry’s 14.3% gain and the S&P 500 composite’s 12.5% rise.

An AFib medical device tested by Novant Health is now helping patients with the disease get off medication. Eva Ingram ...

Summary Medicare covers the Watchman procedure for people with non-valvular AFib who meet specific criteria. The criteria relate to increased stroke risk and suitability for anticoagulation therapy.

The Watchman device offers a safe and effective alternative to long-term blood thinners for patients at risk of stroke due to non-valvular AFib, according to Marian Regional Medical Center.

The main concern with AFib is the elevated risk of stroke, which is where the Watchman device comes in. Since its FDA approval in March 2015, the Watchman has been implanted into nearly 50,000 ...

Your Good Health: I'm a woman with AFib, do I need a WATCHMAN? AFib, a common rhythm disorder, increases the risk of stroke. In asymptomatic people, the most important goal is managing stroke risk.

The WATCHMAN device is an LAA-occlusion device. It blocks the LAA (a small area within the left atrium) and prevents clots that form there from breaking off to the brain and causing a stroke.

DEAR DR. ROACH: I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I’ve been in normal sinus rhythm since having two catheter ablations in 2018. I take ...

Dr. Roach: I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I’ve been in normal sinus rhythm since having two catheter ablations in 2018.

A team in the Cardiac Catheterization Lab recently completed Community Hospital's 500th WATCHMAN implant to treat patients diagnosed with atrial fibrillation, which puts them at higher risk to stroke.